- Home
- APPF vs CORT Comparison
APPF vs CORT Comparison
Compare APPF & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- CORT
- Stock Information
- Founded
- APPF 2006
- CORT 1998
- Country
- APPF United States
- CORT United States
- Employees
- APPF N/A
- CORT N/A
- Industry
- APPF Computer Software: Prepackaged Software
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- APPF Technology
- CORT Health Care
- Exchange
- APPF Nasdaq
- CORT Nasdaq
- Market Cap
- APPF 7.9B
- CORT 7.5B
- IPO Year
- APPF 2015
- CORT N/A
- Fundamental
- Price
- APPF $237.68
- CORT $71.72
- Analyst Decision
- APPF Buy
- CORT Strong Buy
- Analyst Count
- APPF 6
- CORT 4
- Target Price
- APPF $271.20
- CORT $142.00
- AVG Volume (30 Days)
- APPF 273.7K
- CORT 1.6M
- Earning Date
- APPF 07-24-2025
- CORT 07-28-2025
- Dividend Yield
- APPF N/A
- CORT N/A
- EPS Growth
- APPF 158.56
- CORT 8.36
- EPS
- APPF 5.36
- CORT 1.14
- Revenue
- APPF $824,474,000.00
- CORT $685,446,000.00
- Revenue This Year
- APPF $19.35
- CORT $35.83
- Revenue Next Year
- APPF $16.16
- CORT $35.24
- P/E Ratio
- APPF $45.77
- CORT $62.92
- Revenue Growth
- APPF 22.73
- CORT 30.93
- 52 Week Low
- APPF $189.01
- CORT $30.77
- 52 Week High
- APPF $274.56
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- APPF 58.67
- CORT 50.50
- Support Level
- APPF $223.68
- CORT $66.49
- Resistance Level
- APPF $248.85
- CORT $72.49
- Average True Range (ATR)
- APPF 6.46
- CORT 2.85
- MACD
- APPF 0.89
- CORT -0.09
- Stochastic Oscillator
- APPF 62.59
- CORT 49.95
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.